Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Evaluation of Improved Onboard Patient Imaging

NCT: NCT06187103 · ACTIVE_NOT_RECRUITING

NCT IDNCT06187103
StatusACTIVE_NOT_RECRUITING
Start Date2024-07-10
Completion2026-12

Brief Summary

The primary objective of radiation therapy is to deliver a therapeutic dose of radiation precisely to the target while minimizing exposure to healthy surrounding tissues. Image-guided radiation therapy (IGRT) involves acquiring cone beam computed tomography (CBCT) scans just before or during treatment sessions. By comparing the CBCT images with the reference images from the treatment planning process, clinicians can make necessary adjustments to ensure precise targeting and account for any changes that may have occurred since the initial planning. Conventional CBCT technology is, however, limited by several factors including long acquisition times that result in motion artifacts in the image, smaller fields of view that limit the volume of anatomy that can be imaged, poor image quality that limits soft tissue visibility, and artifacts created by dense metal implants. This study will evaluate a novel CBCT imaging solution ("HyperSight") that has the potential to address the challenges of conventional CBCT.

Frequently Asked Questions

What is Evaluation of Improved Onboard Patient Imaging?

Evaluation of Improved Onboard Patient Imaging is a clinical trial registered under NCT06187103. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT06187103?

The current status of NCT06187103 (Evaluation of Improved Onboard Patient Imaging) is: ACTIVE_NOT_RECRUITING.

When did Evaluation of Improved Onboard Patient Imaging start?

Evaluation of Improved Onboard Patient Imaging started on 2024-07-10.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.